Intangible Asset Valuation
Challenges in Valuing Intellectual Property in the Indian Market
Table of contents
- Key Takeaways — Intellectual Property Valuation Challenges in India
- Why Does IP Valuation Matter in India Now?
- Which IP Types Are Valued in India — and How Do They Differ?
- What Are the Three Approaches to IP Valuation?
- Why Is the Absence of an IP Market a Core Challenge?
- Why Is Royalty Rate the Most Contested IP Valuation Input?
- How Does Ind AS 38 Make IP Invisible on the Balance Sheet?
- How Is IP Value Separated from Enterprise Value?
- How Is the Economic Life of Technology IP Determined?
- How Does Transfer Pricing Apply to Cross-Border IP in India?
- What Does PPA Require for IP in Indian M&A Transactions?
- How Is IP Valued in Litigation, Insolvency, and Disputes?
- What Is the Regulatory Framework for IP Valuation in India?
- Brand Valuation in Practice: Relief from Royalty Method
- How Do IP Valuation Challenges Differ Across Indian Sectors?
- How Should Businesses Navigate IP Valuation in India?
- Need an IP Valuation for M&A, Transfer Pricing, or Fundraising? Speak to Our Specialists.
- Valuing IP for M&A, Transfer Pricing, PPA, Fundraising, or Dispute? We Deliver India's Most Rigorous IP Valuations.
- Closing Summary — IP Valuation Challenges in India
- Frequently Asked Questions — Slump Sale Valuation
Part of the Intangible Asset Valuation series. This guide focuses on IP-specific challenges. For the complete framework covering all intangible asset classes, methods, and regulatory requirements, read our pillar guide: Intangible Asset Valuation in India — Complete Guide →
When a Bengaluru SaaS company is acquired by a global technology group, the purchase price allocation (PPA) exercise under Ind AS 103 typically reveals something striking: the IP — software platform, brand, customer relationships, non-compete agreements — that never appeared on the Indian company's balance sheet accounts for 70% or more of the enterprise value. The factories and land are worth a fraction of what the patents, trademarks, and proprietary code are worth. The accountants knew it. The regulators expected it. But nobody had quantified it until a transaction forced the question.
This is the central reality of intellectual property valuation in India today. IP-intensive sectors — technology, pharmaceuticals, FMCG, fintech, media — now dominate Indian M&A, IPO pipelines, and FDI inflows. Yet IP Valuation in India remains one of the most technically demanding, methodologically contested, and practically underserved disciplines in finance. The absence of liquid IP markets, the thinness of India-specific royalty benchmarking data, the accounting invisibility mandated by Ind AS 38, and the intensity of CBDT transfer pricing scrutiny combine to make every IP valuation engagement a specialist exercise — not a standard financial calculation.
This guide dissects every major challenge that IBBI Registered Valuers, CFOs, M&A counsel, and business owners encounter when valuing intellectual property in the Indian market — and sets out how each challenge must be navigated with discipline, documentation, and methodology that will withstand scrutiny in boardrooms, tax tribunals, NCLT proceedings, and investor negotiations.
Key Takeaways — Intellectual Property Valuation Challenges in India
- IP is invisible on most Indian balance sheets — Ind AS 38 prohibits recognition of internally generated brands, goodwill, and customer lists, creating a systematic understatement of business value.
- No liquid IP market exists in India — unlike shares or real estate, IP is rarely transacted in observable arm's-length deals, making the Market Approach difficult to apply reliably.
- Royalty rate benchmarking is the single biggest source of IP valuation disputes in India — whether in transfer pricing, licensing negotiations, or litigation.
- Technology IP has a short and uncertain economic life — forecasting cash flows from patents, software, and algorithms in India's fast-moving tech landscape requires careful, defensible assumptions.
- Transfer pricing of IP (cross-border licensing, IP transfers to subsidiaries) is one of the most litigated areas in Indian tax law — sound IP valuation is essential for tax compliance and dispute avoidance.
- Purchase Price Allocation (PPA) under Ind AS 103 requires identifying and valuing every acquired intangible — driving demand for specialised IP valuation in M&A transactions.
- IBBI Registered Valuers (Business or Securities asset class) are required for statutory IP and intangible valuations under the Companies Act 2013 framework.
- Indian courts and tribunals are increasingly scrutinising IP valuation methodology in IP infringement damages cases, insolvency proceedings, and tax disputes.
Why Does IP Valuation Matter in India Now?
India's economy has undergone a structural transformation. The sectors driving the highest growth, the largest IPOs, and the most significant M&A transactions are overwhelmingly IP-intensive: technology, SaaS, pharmaceuticals, biotechnology, FMCG brands, media and entertainment, fintech, e-commerce, and EdTech. In these industries, the most valuable assets are not factories or land — they are patents, trademarks, software, customer relationships, proprietary data, and brand equity.
Why IP Valuation is No Longer Optional in India
The confluence of M&A activity (India recorded $100 Bn+ in deal value in FY24–25), the IBBI insolvency framework requiring asset valuation in CIRP proceedings, SEBI's disclosure requirements for intangible-heavy companies, the Income Tax Act's transfer pricing provisions for IP, and Ind AS 103 purchase price allocation requirements means that IP valuation now sits at the intersection of every major corporate event — fundraising, M&A, restructuring, taxation, and insolvency.
Yet despite this growing importance, IP valuation in India is systematically underinvested. Most Indian businesses — even large, sophisticated ones — have never had their intellectual property independently valued. CFOs struggle to explain IP value to investors and acquirers. Tax teams routinely face transfer pricing adjustments on IP transactions. Insolvency resolution professionals grapple with valuing IP assets that have no comparable market. This guide addresses the root of each of these problems.
Yet despite this growing importance, IP valuation in India is systematically underinvested. Most Indian businesses — even large, sophisticated ones — have never had their intellectual property independently valued. CFOs struggle to explain IP value to investors and acquirers. Tax teams routinely face transfer pricing adjustments on IP transactions. Insolvency resolution professionals grapple with valuing IP assets that have no comparable market. This guide addresses the root of each of these problems.
Technology & SaaS
Pharmaceuticals & Biotech
FMCG & Consumer Brands
Media & Entertainment
Fintech & Banking
EdTech & E-Commerce
Which IP Types Are Valued in India — and How Do They Differ?
Different types of intellectual property present fundamentally different valuation challenges. The table below maps each IP class to its primary valuation methods and the core difficulty encountered in Indian practice.
🏷️ Trademarks & Brands
Primary Method: Relief from Royalty
India has thousands of powerful regional and national brands. Yet most remain unvalued and unrecognised on balance sheets. Key challenges:
- Determining the correct royalty rate for Indian brand categories
- Segregating branded vs. unbranded revenue streams
- Assessing brand strength in regionally fragmented markets
- Ind AS 38 prohibition on internally generated brands
🔬 Patents & Technology Know-How
Primary Method: MEEM / Relief from Royalty
Most relevant in pharmaceuticals, chemicals, and engineering. Key challenges:
- Short, uncertain economic life — especially for technology patents
- Difficulty forecasting incremental revenue attributable to the patent
- Patent cliff risk (post-expiry value erosion in pharma)
- Benchmarking royalty rates in India-specific patent categories
💻 Software & Proprietary Technology
Primary Method: Cost / With-and-Without
India's most prolific IP category, yet most challenging to value. Key challenges:
- High obsolescence risk — technology cycles of 2–5 years
- Difficulty separating platform value from human capital
- Replacement cost rapidly becomes redundant for legacy systems
- SaaS platforms blur the line between product and service
🤝 Customer Relationships & Contracts
Primary Method: Multi-Period Excess Earnings
Critical in B2B technology, financial services, and telecom. Key challenges:
- Customer attrition rate assumptions — highly sensitive input
- Contributory asset charges (CAC) — complex to calculate
- Contract-based vs. relationship-based customer value distinction
- Privacy laws restricting disclosure of customer data to valuers
📄 Copyrights & Content
Primary Method: Income / Relief from Royalty
Driven by India's booming media, publishing, and OTT landscape. Key challenges:
- Forecasting content monetisation across multiple platforms
- Quantifying streaming vs. theatrical vs. syndication revenue
- Copyright term certainty and renewal assumptions
- Thin comparable transaction data for Indian content deals
🌐 Goodwill & Going Concern Value
Primary Method: Residual / Excess Earnings
One of the most contested intangibles in Indian M&A and insolvency. Key challenges:
- Ind AS 103 prohibits recognising acquired goodwill separately — it is a residual
- Internally generated goodwill: prohibited under Ind AS 38
- Impairment testing under Ind AS 36 — subjectivity in CGU allocation
- Goodwill frequently emerges in CIRP proceedings as a disputed asset
What Are the Three Approaches to IP Valuation?
All IP valuation in India — whether for M&A, tax, litigation, or regulatory compliance — draws on three foundational approaches, consistent with the International Valuation Standards Council (IVSC) framework, ISO 10668 (brand valuation), ISO 17369, and the IBBI Valuation Standards. Understanding each approach — and where it works and fails in the Indian market — is fundamental.
The Three Approaches to IP Valuation
Income Approach — Market Approach — Cost Approach
Income Approach
Relief from Royalty (RfR) = Σ [ (Revenue × Royalty Rate × Tax-Effected Factor) ÷ (1 + WACC)t ]
Multi-Period Excess Earnings (MEEM) = Σ [ (Revenues − Costs − CACs) ÷ (1 + Discount Rate)t ]
With-and-Without Method = PV(Business WITH IP) − PV(Business WITHOUT IP)
Market Approach
IP Value = Comparable Transaction Price × Size / Revenue Adjustment Factor
Cost Approach
Replacement Cost = Cost to recreate equivalent IP at today's cost
Reproduction Cost = Cost to recreate identical IP at today's cost
Both cost methods adjusted for: Functional obsolescence + Economic obsolescence + Physical deterioration
⚠️ India-Specific Caution
The Market Approach is theoretically attractive but practically limited in India for most IP classes — observable, arm's-length IP transactions are rare, and publicly disclosed deal terms for IP are rarer still. Indian practitioners should be careful about applying foreign royalty rate databases (such as RoyaltyRange, RoyaltyStat, or ktMINE) without adjusting for India-specific risk, market conditions, and industry dynamics. The Income Approach — particularly Relief from Royalty and MEEM — is the dominant methodology in Indian IP valuation practice.
Why Is the Absence of an IP Market a Core Challenge?
In equity valuation, a listed company's shares trade millions of times a day — providing a continuous, transparent, market-validated reference price. In real estate, thousands of transactions occur annually in every city, yielding solid comparable data. Intellectual property enjoys no such luxury.
In India, the IP market is characterised by: thin transaction volumes, private deal terms rarely disclosed, fragmented sector coverage, and a near-total absence of IP auction platforms or exchanges. This creates a fundamental challenge for every IP valuer: there is rarely a directly comparable, arm's-length IP transaction to anchor the valuation.
✅ How to Navigate the Comparables Problem
Use a hybrid approach — identify the closest available international comparables from royalty databases, apply India-specific adjustments (market risk premium differential, sector growth rate differences, regulatory environment), corroborate with the Income Approach, and explicitly document the comparable selection and adjustment methodology in the valuation report. Qualitative factors (IP strength, market position, remaining legal term) should inform any quantitative adjustments.
Why Is Royalty Rate the Most Contested IP Valuation Input?
The royalty rate is the single most consequential input in the Relief from Royalty method — the dominant approach for brand and patent valuation in India. A difference of just 1–2 percentage points in the royalty rate can change IP value by 30–50% or more. It is no coincidence that royalty rate disputes are at the heart of the majority of Indian transfer pricing litigation involving IP.
Why Royalty Rate Is So Impactful — Brand Valuation Sensitivity
Brand Value = PV of (Branded Revenue × Royalty Rate × Tax-Effected Factor)
Inputs:
Branded Revenue = ₹500 Cr per year
Discount Rate = 15% | Economic Life = 10 years
Calculation — Royalty Rate Scenarios:
Royalty Rate 2% → Annual Royalty ₹10 Cr → PV of Royalties ≈ ₹50 Cr
Royalty Rate 4% → Annual Royalty ₹20 Cr → PV of Royalties ≈ ₹100 Cr
Royalty Rate 6% → Annual Royalty ₹30 Cr → PV of Royalties ≈ ₹150 Cr
A 4-percentage-point spread in royalty rate triples the brand value — this is why royalty rate selection is the most contested element in Indian IP valuation.
The Factors That Drive Royalty Rate in India
1. Industry and IP Category
Pharmaceutical royalty rates differ vastly from technology or consumer brand royalty rates. Indian sector-specific norms (often informed by global data with local adjustment) must be applied.
2. IP Strength and Legal Protection
A registered trademark with 20-year protection and strong market recognition commands a higher royalty than an unregistered brand in a contested category. IP legal status directly affects the rate.
3. Profitability of the Licensee Business
The 25% Rule of Thumb (licensee keeps 75% of operating profit, licensor receives 25%) is frequently referenced — though it has been challenged in many jurisdictions including India.
4. Exclusivity and Scope of the Licence
Exclusive licences command a higher royalty rate than non-exclusive licences. Geography, field of use, and duration all affect the rate. Indian valuers must carefully specify the hypothetical licence terms being assumed.
5. Comparable Licence Agreements
Internal comparable uncontrolled transactions (CUTs) — actual third-party licence agreements involving the same or similar IP — are the most reliable evidence of arm's-length royalty rates for transfer pricing purposes.
⚠️ Transfer Pricing Red Flag
The Indian Income Tax Department (CBDT) and Income Tax Appellate Tribunal (ITAT) have repeatedly rejected royalty rates in cross-border IP transactions that were determined without adequate comparable benchmarking, without consideration of functions, assets, and risks (FAR analysis), or without a contemporaneous valuation report. Under the BEPS Action Plan 8–10 framework (Hard-to-Value Intangibles), the tax authority can apply ex-post adjustments even when the taxpayer used good-faith projections at the time of the transaction.
How Does Ind AS 38 Make IP Invisible on the Balance Sheet?
One of the most profound structural challenges in IP valuation in India is the systematic invisibility of IP on Indian company balance sheets. Ind AS 38 (Intangible Assets) — India's accounting standard for intangibles — prohibits the recognition of internally generated goodwill, brands, customer lists, and publishing titles. Only IP that is acquired externally (through purchase or in a business combination) can be recognised at cost or fair value.
What Ind AS 38 PROHIBITS recognising
₹0
Internally generated brands, goodwill, customer relationships, mastheads, publishing titles, research-phase expenditure — even if worth thousands of crores in economic reality.
What Ind AS 38 PROHIBITS recognising
₹0
Separately acquired IP (patents, trademarks purchased), IP acquired in a business combination (Ind AS 103 PPA), and development-phase expenditure meeting strict criteria.
- This creates a fundamental tension in IP valuation engagements in India:
- A company may be worth ₹1,000 Cr based on its brand and IP — but its balance sheet shows net assets of ₹80 Cr. Investors, lenders, and acquirers who rely on book value alone massively underestimate value.
- Internally developed software platforms — capitalised as development costs only if strict Ind AS 38 criteria are met — are often expensed immediately, understating asset base.
- Impairment testing under Ind AS 36 for goodwill and indefinite-life intangibles requires annual Cash Generating Unit (CGU) value-in-use calculations — but with no recognised balance sheet value for internally generated IP, the impairment test is incomplete.
- When an IP-rich Indian company raises equity, investors must rely on off-balance-sheet IP valuation rather than any recognised accounting value — increasing information asymmetry and valuation subjectivity.
🔵 Ind AS 103 Exception — Purchase Price Allocation
The one scenario where internally generated IP becomes visible on the balance sheet is a business combination. Under Ind AS 103, when a company is acquired, all of its identifiable intangible assets — including brands, customer relationships, technology, non-competes, and in-process R&D — must be separately identified and measured at fair value on the acquisition date. This PPA exercise makes acquired IP visible, but only for the acquirer, and only for IP that meets the identifiable criterion (i.e., is separable or arises from contractual/legal rights).
Need an IP Valuation for M&A, Transfer Pricing, or Fundraising? Speak to Our Specialists.
Our IBBI Registered Valuers and intangible asset specialists deliver defensible, methodology-first IP valuations — for brands, patents, software, customer relationships, goodwill, and all other intangible assets — across every major sector in India. We combine deep domain expertise with India-specific benchmarking to deliver valuations that stand up to scrutiny in boardrooms, tax tribunals, and courts.
How Is IP Value Separated from Enterprise Value?
Perhaps the most technically demanding challenge in IP valuation is the isolation of value attributable to a specific IP asset from the overall enterprise value. In most businesses, IP does not operate independently — it is embedded in a business system that includes people, processes, capital, and relationships. Untangling the IP's specific contribution is a complex, judgment-intensive process.
Example — SaaS Company Valuation
A SaaS company is valued at ₹500 Cr. This value is generated by its proprietary software platform (technology IP), its brand recognition among target customers, its trained workforce, its customer contracts, and its sales and distribution infrastructure. Which portion of the ₹500 Cr is attributable to the software platform alone? This is not a simple question — and the answer changes depending on the purpose of the valuation (M&A, PPA, transfer pricing, insolvency, licensing).
The Contributory Asset Charge (CAC) — The Key Technical Tool
The Multi-Period Excess Earnings Method (MEEM) addresses this by introducing Contributory Asset Charges (CACs) — notional charges for the use of all assets other than the IP being valued (working capital, fixed assets, workforce, other intangibles). After deducting CACs from the business's total earnings, the residual is attributable to the IP being valued. The challenge lies in:
- Identifying every contributing asset (including assembled workforce — a non-recognised intangible under Ind AS 38)
- Determining the appropriate return rate for each contributing asset class
- Avoiding double-counting across IP categories (e.g., technology and customer relationships often contribute simultaneously)
- Ensuring the sum of all intangible + tangible asset values does not exceed enterprise value (the "value reconciliation" test)
How Is the Economic Life of Technology IP Determined?
The value of IP is the present value of the economic benefits it generates over its remaining useful life. Determining the economic life of technology IP in India's rapidly evolving digital economy is one of the most subjective — and consequential — inputs in any IP valuation.
How Does Transfer Pricing Apply to Cross-Border IP in India?
For Indian multinationals, technology companies, and foreign-owned subsidiaries, transfer pricing of IP is the single most litigated area in Indian tax law. When an Indian entity transfers IP to, or licenses IP from, a related foreign entity (parent, subsidiary, or associate), the Income Tax Act (Chapter X, Section 92) requires the transaction to be priced at arm's length — the price that unrelated parties would have agreed in similar circumstances. The SEBI and IBBI frameworks additionally require IP valuation disclosures in listed company transactions and insolvency proceedings respectively. For a detailed treatment of cross-border valuation compliance, see our Cross-Border M&A Valuation guide.
⚠️ The BEPS Hard-to-Value Intangibles (HTVI) Problem in India
Under OECD BEPS Action Plans 8–10 (which India has substantially adopted), intangibles that are "hard to value" at the time of the transaction — because financial projections are highly uncertain — can be subjected to ex-post adjustments by the tax authority. This means the Indian Income Tax Department can, in principle, use actual outcomes (revenue, profits achieved post-transfer) to challenge the IP transfer price that was used years earlier, even if the taxpayer used best-efforts estimates at the time.
| Transfer Pricing Issue | IP Type Affected | Risk Level in India | Key Mitigation |
|---|---|---|---|
| Under-pricing IP transfer to foreign subsidiary | Patents, Software, Know-How | 🔴Very High | Independent valuation + APA filing |
| Excessive royalty paid to foreign parent | Trademarks, Brand Licences | 🔴Very High | CUT benchmarking + Form 3CEB documentation |
| IP migration / restructuring (offshore to India) | All IP types | 🟠High | Functional analysis + HTVI valuation report |
| Cost contribution arrangements (CCA) for R&D | Technology, Pharma R&D | 🟠High | Reasonably anticipated benefit analysis |
| Intragroup software licence charges | Enterprise Software | 🟡Medium | TNMM benchmarking + proper licence agreement |
✅ The Advance Pricing Agreement (APA) Route
India's APA programme (introduced in 2012) allows taxpayers to pre-agree the arm's length price — including the royalty rate for IP — with the Central Board of Direct Taxes (CBDT) for a period of 5 years (bilateral APAs can extend further). For companies with recurring cross-border IP licensing arrangements, an APA significantly reduces transfer pricing risk and audit exposure. Our IP valuation reports are specifically structured to support both transfer pricing documentation (Form 3CEB) and APA applications.
What Does PPA Require for IP in Indian M&A Transactions?
Every M&A transaction involving an Indian company that adopts Ind AS triggers a Purchase Price Allocation (PPA) exercise under Ind AS 103 (Business Combinations). PPA requires the acquirer to identify and measure at fair value every identifiable intangible asset acquired — meaning IP that was invisible on the target's balance sheet must now be valued and recognised.
Identify Acquisition Price
Identify All Tangible Assets & Liabilities at FV
Identify & Value All Intangible Assets
Residual = Goodwill
Amortise Finite-Life Intangibles
Annual Impairment Test
⚠️ The PPA Time Pressure Problem
Under Ind AS 103, the acquirer has a measurement period of up to 12 months after the acquisition date to finalise the PPA. In practice, Indian acquirers frequently underestimate the complexity of the PPA exercise and either delay it (triggering audit qualifications) or produce cursory valuations that do not withstand scrutiny from auditors or regulators. An early-engagement, specialist IP valuation team — engaged alongside or shortly after the deal team — is essential to avoid a rushed, low-quality PPA.
How Is IP Valued in Litigation, Insolvency, and Disputes?
Beyond transactional and compliance contexts, IP valuation increasingly features in Indian litigation, insolvency proceedings, and commercial disputes. The contexts are varied — IP infringement damages quantum, CIRP resolution under the IBC, family business partition disputes, and shareholder oppression remedies under the Companies Act — but the underlying challenge is consistent: producing a valuation that is credible, methodology-sound, and defensible before a court or tribunal.
What Is the Regulatory Framework for IP Valuation in India?
IP valuation in India does not occur in a regulatory vacuum. Multiple statutes, regulations, and accounting standards prescribe when IP valuation is required, who can conduct it, and what methodology must be followed. The primary regulatory instruments include the IBBI Valuation Standards (particularly Valuation Standard 4 on Intangible Assets), Ind AS 38 notified by MCA, and Chapter X of the Income Tax Act governing transfer pricing. Understanding this framework is essential for compliance. For cross-border IP transactions, see also our guide on FEMA Valuation in India, and for IP-heavy M&A deals our M&A Valuation guide covers the full transaction valuation framework.
| Regulatory Context | Applicable Law / Standard | Valuer Qualification Required | Key Requirement |
|---|---|---|---|
| Business Combinations (M&A PPA) | Ind AS 103, Companies Act 2013 | IBBI Registered Valuer (Business) | Fair value of all acquired intangibles at acquisition date |
| Capital Restructuring / Sweat Equity | Companies Act Sec 54, SEBI (SBEB) | IBBI Registered Valuer | Valuation of IP contributed as consideration for sweat equity |
| Cross-Border IP Transfer / Licensing | Income Tax Act Ch. X (Transfer Pricing) | CA / Transfer Pricing Specialist | Arm's length pricing — Form 3CEB, TP documentation |
| FDI / FEMA Compliance | FEMA 20(R), RBI Master Directions | IBBI Registered Valuer / CA | Valuation of IP contributed as FDI (non-cash consideration) |
| Insolvency (CIRP) | IBC 2016, IBBI Insolvency Regulations | IBBI Registered Valuer (Business) | Fair value and liquidation value of IP assets |
| Impairment Testing | Ind AS 36 | IBBI Registered Valuer / Management | Annual recoverable amount of goodwill and indefinite-life IP |
| ESOP / Sweat Equity (Startups) | Companies Act, SEBI SBEB Regs | IBBI Registered Valuer | Fair value of IP contributed as ESOP / sweat equity component |
Brand Valuation in Practice: Relief from Royalty Method
To make the methodology concrete, we walk through a simplified Relief from Royalty brand valuation for a fictional Indian FMCG company — Marigold Foods Private Limited — which owns the "Marigold" brand across its packaged foods range.
Assignment Context
Marigold Foods is being acquired by a strategic investor. The acquirer requires a standalone valuation of the Marigold brand for Ind AS 103 Purchase Price Allocation purposes. The brand has never appeared on the balance sheet (internally generated, prohibited under Ind AS 38). The acquirer's total consideration is ₹400 Cr for 100% of the business.
Step-by-Step: Relief from Royalty — Marigold Brand Valuation
Brand Value = PV of After-Tax Royalty Stream + Tax Amortisation Benefit
Step 1: Identify Branded Revenue
Total Company Revenue (FY26) = ₹250 Cr
Revenue Attributable to Brand = 80% (packaged retail; remainder is B2B commodity)
Branded Revenue = ₹200 Cr
Step 2: Determine Royalty Rate
Comparable Brand Licences (FMCG) = 2.5%–4.5% (international database, India-adjusted)
Brand Strength Score = 62/100 — Regional Leader, 15 years established
Selected Royalty Rate = 3.5% | Annual Pre-Tax Royalty = ₹200 Cr × 3.5% = ₹7.0 Cr
Step 3: Tax-Effect the Royalty (corporate tax 25.17%)
Post-Tax Royalty per Year = ₹7.0 Cr × (1 – 25.17%) = ₹5.24 Cr
Step 4: Project Branded Revenue Growth
Year 1–5 = 12% CAGR (sector growth + market share gains)
Year 6–10 = 7% CAGR (mature phase)
Terminal = 3.5% perpetuity growth rate
Step 5: Select Discount Rate (Brand-Specific WACC)
Company WACC = 14.5% Brand-Specific Risk Adjustment = +1.5% (regional brand, some concentration risk) Brand Discount Rate = 16.0%
Step 6: Calculate Present Value of Royalty Stream
PV of Year 1–10 After-Tax Royalties = ₹39.2 Cr
PV of Terminal Value = ₹28.6 Cr
Tax Amortisation Benefit (TAB) = ₹9.4 Cr
Brand Value (Relief from Royalty, post-TAB) = ₹77.2 Cr — representing ~19.3% of total acquisition consideration of ₹400 Cr
✅ Valuation Reconciliation Check
After assigning values to all identified intangibles (brand ₹77.2 Cr, customer relationships ₹42 Cr, proprietary recipes/know-how ₹18 Cr, non-compete ₹8 Cr) and net tangible assets (₹96 Cr), the residual goodwill equals ₹158.8 Cr — representing synergies, assembled workforce, and unidentifiable going concern value. This residual is reasonable (below 40% of total deal value) and passes the "smell test" for an FMCG acquisition of this type. All figures are fictional and illustrative only.
How Do IP Valuation Challenges Differ Across Indian Sectors?
IP valuation challenges in India are not uniform — they vary significantly by sector. Below are the most important sector-specific nuances that any IP valuer or business owner must understand.
How Should Businesses Navigate IP Valuation in India?
For business owners, CFOs, M&A lawyers, and investment professionals navigating IP valuation in India, the following framework addresses the most common challenges systematically.
1. Start with IP Audit — Know What You Own
Before any valuation exercise, conduct a structured IP audit: catalogue all registered and unregistered IP (trademarks, patents, copyrights, designs, software, trade secrets, domain names), map each IP asset to the revenue stream it supports, and confirm legal ownership. Many Indian businesses have IP registered in individual promoter names rather than the company — a critical issue in M&A, fundraising, and transfer pricing.
2. Match Methodology to Purpose — One Size Never Fits All
The valuation approach must be matched to purpose: Relief from Royalty for brand licensing or transfer pricing, MEEM for PPA customer relationships, Cost Approach for legacy software in insolvency. Using the wrong method for the wrong purpose — even if the calculation is technically correct — produces a defensively weak valuation report.
3. Build an India-Specific Royalty Benchmarking Database
Do not rely solely on foreign royalty databases. Supplement with: published licence agreements from Indian industry (TRAI, pharma filings, sectoral regulators), FEMA remittance data for intragroup royalties, publicly disclosed M&A deal terms with IP components, and India-specific sector studies. Document every benchmark and justify every adjustment.
4. Conduct Sensitivity Analysis — Stress-Test the Key Inputs
Royalty rate, growth rate, discount rate, and economic life are the four inputs most likely to be challenged. For every IP valuation, run a sensitivity table showing how the IP value changes across a reasonable range of each key input. This both strengthens the valuation report's credibility and helps the client understand the range of defensible outcomes.
5. Engage an IBBI Registered Valuer for Statutory Assignments
For any IP valuation required under the Companies Act 2013, IBBI Insolvency Regulations, FEMA, or for purposes where a Registered Valuer's report is expected by regulators, ensure the valuer is an IBBI Registered Valuer (Business asset class). Non-registered valuers' reports — however technically competent — are not accepted for statutory purposes.
6. Prepare Transfer Pricing Documentation Proactively
For companies with cross-border IP arrangements, prepare contemporaneous TP documentation (Section 92D, Rule 10D) well before the financial year end. An independent IP valuation as part of the TP documentation reduces the risk of the CBDT proposing ex-post adjustments. For significant IP transfers, consider filing an APA application.
7. Reconcile IP Values Against Enterprise Value
Every PPA or standalone IP valuation should pass the reconciliation test: the sum of fair values of all identified net assets (tangible + intangible) should not exceed the total enterprise value, and the implied goodwill should be reasonable for the sector and transaction type. An IP value that creates negative goodwill (or implausibly small goodwill) in an M&A context is a red flag that will be challenged by auditors.
Valuing IP for M&A, Transfer Pricing, PPA, Fundraising, or Dispute? We Deliver India's Most Rigorous IP Valuations.
From brand valuation and patent valuation to full Purchase Price Allocation, transfer pricing IP documentation, FEMA compliance, insolvency IP valuation, and litigation damages — our IBBI Registered Valuers and intangible specialists deliver IP valuation reports that are methodology-first, India-benchmarked, and built to withstand scrutiny. One engagement. Complete methodology. Defensible outcomes.
Closing Summary — IP Valuation Challenges in India
Intellectual property valuation in India sits at the convergence of accounting standards, regulatory compliance, transfer pricing law, and commercial reality — and the gaps between these frameworks create complexity that no template-driven approach can resolve. The absence of liquid IP markets, the Ind AS 38 invisibility of internally generated IP, the intensity of CBDT transfer pricing scrutiny, and the increasing role of IP valuation in NCLT insolvency proceedings and court-ordered damages assessments mean that the standard of practice demanded from Indian IP valuers has risen materially. For CFOs, M&A counsel, and business owners, the imperative is clear: engage IBBI Registered Valuers with genuine intangible asset specialisation, early in the transaction or compliance cycle, with a methodology and benchmarking rigour that can withstand regulatory and judicial scrutiny. Elite Valuation's IBBI Registered Valuers bring exactly that — sector-specific IP valuation expertise, India-benchmarked methodologies, and defensible reports built for the full spectrum of IP valuation contexts in India.
Frequently Asked Questions — Slump Sale Valuation
CA Sagar Shah, Founder
Mr Sagar Shah is the Founder of Elite Valuation and leads the firm’s Valuation and Advisory practice. With over 15+ years of professional experience.
